SEC Form 4 · accession 0001354488-15-004726
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wei (William) Cao
Officer — Chief Executive Officer · Director
Period of report
Sep 30, 2013
Accepted (ET)
Oct 26, 2015 · 7:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 20, 2015 | M | 5,013 | $5.40 | A | 227,531 | D | |
| Common Stock | Oct 20, 2015 | S | 5,013 | $18.89 | D | 222,518 | D | |
| Common Stock | Oct 21, 2015 | M | 14,987 | $5.40 | A | 237,505 | D | |
| Common Stock | Oct 21, 2015 | S | 14,987 | $19.83 | D | 222,518 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non- Qualified Stock OptionF2 | $5.40 | Sep 30, 2013 | A | 90,000 | A | — | Sep 29, 2023 | Common Stock | 90,000 | 90,000 | D |
| Non- Qualified Stock OptionF2 | $5.40 | Oct 20, 2015 | M | 5,013 | A | — | Sep 29, 2023 | Common Stock | 5,013 | 84,987 | D |
| Non- Qualified Stock OptionF2 | $5.40 | Oct 21, 2015 | M | 14,987 | A | — | Sep 29, 2023 | Common Stock | 14,987 | 70,000 | D |
Explanation of responses
- F1The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- F2This option vests over a period of three-year years according to the following schedule: 1/36th per month following the vesting commencement date of 09/30/2013.